Performance Report And Forecasts For Climb Bio Inc (NASDAQ: CLYM)

In the latest trading session, 2.76 million Climb Bio Inc (NASDAQ:CLYM) shares changed hands as the company’s beta touched -0.26. With the company’s most recent per share price at $1.90 changed hands at -$0.02 or -1.27% at last look, the market valuation stands at $127.44M. CLYM’s current price is a discount, trading about -507.89% off its 52-week high of $11.55. The share price had its 52-week low at $1.73, which suggests the last value was 8.95% up since then. When we look at Climb Bio Inc’s average trading volume, we note the 10-day average is 0.49 million shares, with the 3-month average coming to 346.89K.

Climb Bio Inc (NASDAQ:CLYM) trade information

Instantly CLYM was in red as seen in intraday trades today. With action -17.58%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 5.32%, with the 5-day performance at -17.58% in the red. However, in the 30-day time frame, Climb Bio Inc (NASDAQ:CLYM) is -38.85% down. Looking at the short shares, we see there were 4.82 million shares sold at short interest cover period of 13.74 days.

Climb Bio Inc (CLYM) estimates and forecasts

Data shows that the Climb Bio Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -72.88% over the past 6 months, a -20.77% in annual growth rate that is considerably lower than the industry average of 16.70%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -46.72%.

Climb Bio Inc (NASDAQ:CLYM)’s Major holders

Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 899.65 shares estimated at $1.72 million under it, the former controlled 1.34% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 1.08% of the shares, roughly 723.54 shares worth around $1.38 million.